JO
TSVT

John Overdeck’s 2seventy bio TSVT Stock Holding History

John Overdeck’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,100
Closed -$47.4K – 3399
2023
Q4 		$47.4K Buy
+11,100
New +$34.1K ﹤0.01% 2999
2023
Q3 		– Sell
-115,446
Closed -$1.17M – 3223
2023
Q2 		$1.17M Buy
+115,446
New +$1.22M ﹤0.01% 1860

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

John Overdeck's TSVT Position: Q1 2024 in Review

John Overdeck sold out of 2seventy bio (TSVT) in Q1 2024, closing a stake of 11,100 shares — an estimated $47.4K sold.

John Overdeck first reported a position in TSVT in Q2 2023 and held it in 2 quarters. The position peaked at $1.17M in Q2 2023. 117 funds tracked by Wall St. Rank hold TSVT as of Q1 2024.

  • John Overdeck reported no remaining 2seventy bio position as of Q1 2024 after selling out during the quarter.
  • John Overdeck sold 11,100 2seventy bio shares in Q1 2024, an estimated $47.4K.
  • John Overdeck first reported a position in 2seventy bio in Q2 2023 and held it in 2 quarters.
  • John Overdeck's 2seventy bio position peaked at $1.17M in Q2 2023.
  • 117 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.